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Cardiovascular autonomic neuropathy (CAN) is a frequent complication of diabetes mellitus, which is associated 
with increased morbidity and mortality. It involves both the parasympathetic and sympathetic nervous systems, 
and may be diagnosed by classical dynamic tests with measurements of heart rate (HR) and/or arterial blood 
pressure (BP). An original squattest (1-min standing, 1-min squatting, 1-min standing) was used with continuous 
monitoring of HR and BP, using a Finapres® device. This active test imposes greater postural stress than the 
passive head-up tilt test, and provokes large changes in BP and HR that can be analyzed to derive indices of 
CAN. In healthy subjects, squatting is associated with BP increases and HR decreases (abolished by atropine: 
SqTv index), whereas the squat-stand transition is accompanied by a deep but transient drop in BP associated 
with sympathetic-driven tachycardia (abolished by propranolol: SqTs index). In diabetic patients with CAN, BP 
increases are accentuated during squatting whereas reflex bradycardia is reduced. When standing from squatting 
position, the fall in BP tends to be more pronounced and orthostatic hypotension more prolonged, while reflex 
tachycardia is markedly dampened. The baroreflex gain, similar to that calculated during pharmacological testing 
with vasodilator/vasopressor agents, can be derived by plotting pulse intervals (R-R) against systolic BP levels 
during the biphasic response following the squat-stand transition. The slope, which represents baroreflex 
sensitivity, is significantly reduced in patients with CAN. This discriminatory index allows study of the natural 
history of CAN in a large cohort of diabetic patients.  
Keywords: Baroreflex sensitivity; Cardiovascular autonomic neuropathy; Finapres ; Squatting; Diabetes; Heart 
rate; Orthostatic hypotension; Posture test; Review 
Résumé 
Test postural d' accroupissement pour étudier la neuropathie autonome cardiovasculaire diabétique. 
La neuropathie autonome cardiaque (NAC) est une complication fréquente du diabète qui est associée à une 
augmentation de la morbidité et de la mortalité. Elle concerne à la fois les systèmes parasympathique et 
sympathique et peut être diagnostiquée classiquement par des tests dynamiques avec mesure des variations de la 
frequence cardiaque (FC) et de la pression artérielle (PA). Notre groupe a utilise un test postural original (1-min 
debout-1 -min accroupi ou « squatting »-1 -min debout) avec un monitorage continu de FC et PA avec un 
appareil Finapres®. Ce test de redressement actif impose un stress postural plus prononcé que le test d'inclinaison 
passif sur une table basculante et provoque des variations amp les de PA et FC qui peuvent être analysées pour 
dériver des indices de NAC. Chez des sujets sains, le «squatting» entraîne une augmentation de PA et une 
diminution de FC (abolie par l'atropine : indice SqTv) alors que la transition accroupi-debout induit une chute 
importante mais transitoire de PA accompagnée d'une tachycardie d'origine sympathique (abolie par le 
propranolol : indice SqTs). Chez les patients diabétiques avec NAC, l'augmentation de PA durant le « squatting 
» est accentuée alors que la bradycardie réflexe est réduite. Lors du passage de la position accroupie à la position 
debout, la chute de PA tend à être plus marquee et surtout plus prolongée alors que la tachycardie réflexe est 
amputee. Un gain baroréflexe, similaire à celui calculé lors d'un test pharmacologique avec des agents 
vasodilatateurs/vasopresseurs, peut être dérivé de la pente de la relation linéaire entre les intervalles R-R et la PA 
systolique suivant la transition accroupi-debout. Cette pente, qui représente la sensibilité du baroréflexe, est 
significativement diminuée chez les patients avec NAC. Cet indice performant nous a permis d'étudier l'histoire 
naturelle de la NAC dans une large cohorte de patients diabétiques. . 
Mots clés : Baroréflexe ; Diabète ; Finapres® ; Fréquence cardiaque ; Hypotension orthostatique ; Neuropathie 
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1.  Introduction 
Cardiovascular autonomic neuropathy (CAN) is a classical, albeit underestimated, complication of diabetes 
mellitus (DM) in both type 1 (T1DM) and type 2 (T2DM) categories [1,2]. The most recognized features 
associated with CAN are reduced heart rate (HR) variability [3] and postural hypotension [4]. CAN is 
responsible for an increased risk in mortality, as revealed by a meta-analysis published in 2003 [5], and 
confirmed by two recent studies of patients with T1DM [6] and T2DM [7]. Therefore, the early diagnosis of 
CAN is recommended in clinical practice [1]. 
Non-invasive continuous monitoring of HR and arterial blood pressure (BP), using devices such as Finapres® 
and Finometer®, has greatly facilitated the study of haemodynamic changes during posture tests in clinical 
research and practice [8,9]. Various posture tests are classically used to assess haemodynamic adaptation and 
autonomic function [10, 11]. The most commonly used tests are the lying-to-standing active manoeuvre in 
clinical practice, and the head-up 70°-tilt table test passive manoeuvre in clinical research [11]. Another active 
test, the so-called squat test, produces the strongest orthostatic stress [10, 12], more so than the head-up tilt [10, 
13, 14], and can therefore be used to assess autonomic dysfunction [15]. Indeed, careful analysis of BP and HR 
changes during the transitions from standing to squatting and, even more interesting, from squatting to standing, 
provides invaluable information [8]. The squat test can be used to assess autonomic dysfunction especially 
through calculation ofthe so-called baroreflex gain [12, 15]. Our research group [16], as with others [13, 17, 18], 
was particularly interested in applying this original potent posture test to assess diabetic CAN. 
The aim of the present review was to analyze the information obtained by continuously measuring BP and HR 
changes during a squat test to derive indices of CAN in patients with T1DM and T2DM (Table 1). 
 
2.  Guidelines for the detection of cardiovascular autonomic neuropathy (CAN) 
The CAN Subcommittee of Toronto Consensus Panel on Diabetic Neuropathy recently published updated 
guidelines that were especially focused on the diagnosis and usefulness of CAN testing [1]. Criteria for CAN 
diagnosis and staging are: 
•  one abnormal cardiovagal test to identify possible or early CAN; 
•  at least two abnormal cardiovagal tests to identify definite or confirmed CAN; 
•  the presence of orthostatic hypotension, in addition to HR test abnormalities, to identify severe or advanced 
CAN. 
Progressive stages of CAN are associated with an increasingly poorer prognosis. 
The same committee critically reviewed the limitations and strengths of the available diagnostic approaches for 
CAN, and emphasized the need to develop new tests for autonomic function. It was concluded that the most 
sensitive and specific approaches currently available to evaluate CAN in clinical research are: 
•  HR variability; 
•  baroreflex sensitivity; 
•  muscle sympathetic nerve activity; 
•  plasma catecholamines; 
•  heart sympathetic imaging. 
It was also recommended that efforts be undertaken to develop new non-invasive and safe CAN tests to be used 
in clinical research with higher sensitivity and specificity for studying the pathophysiology of CAN, as well as 
new therapeutic approaches [11]. 
3. Haemodynamic changes during squatting and the squat-stand transition 
Our experimental squat test protocol (1-min standing, 1-min squatting, 1-min standing) included two successive 
transitions: first, from standing to squatting; and, second, from squatting to standing. Each transition provokes 
specific haemodynamic changes that can be monitored by a Finapres device, as recently described in detail 
elsewhere (Fig. 1) [12]. 
The transition from standing to squatting elicits muscle pumping and increased venous return, which leads to 
prompt increases in cardiac output, systolic BP, and pulse pressure (PP), followed by reflex bradycardia [ 12, 
19]. Bradycardia was shown to be significantly dampened by the administration of atropine in healthy 
volunteers, consistent with vagal activation [17], and was not observed in heart transplant recipients [20]. 
Forearm vascular resistance was markedly decreased in squatting position in healthy individuals, but only 
minimally in patients with heart transplants, despite similar BP increases [20]. 
The squat-stand transition provokes an immediate sizeable reduction in BP, reflecting an instantaneous fall in 
systemic vascular resistance due to vasodilatation in the leg muscles (an effect that can be minimized by lower-
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body skeletal muscle-tensing) [21,22]. In normal, healthy subjects, cardiac output increases over the first 5 s after 
standing from squatting position due to compression of the leg and abdominal vessels. Rapid (within 15-20 s) BP 
recovery implies baroreflex stimulation [8], which is associated with tachycardia and secondary peripheral 
vasoconstriction [12,15]. Propranolol can markedly attenuate reflex tachycardia in normal subjects, suggesting 
that sympathetic activation plays a key role in this abrupt HR rise [17]. 
 
Table 1 : Summary of haemodynamic changes, derived indices and abnormalities in the presence of 
cardiovascular autonomic neuropathy (CAN) during the three successive phases of the squat test (standing-
squatting-standing). 
Posture Standing Squatting Standing 
Haemodynamic 
changes 
Baseline ↑ BP ↓ BP (transient) 
↑ PP ↓HR ↑ HR (transient) 
Squatting-derived 
indices 
 SqTv SqTs 
Baroreflex gain 
Abnormalities in 
presence of CAN 




↑ SqTv ↓ SqTs 







↑: increased; ↓: decreased; BP: blood pressure; PP: pulse pressure; HR: heart rate; SqTv: vagal index, or ratio between baseline cardiac R-R 
interval in initial standing position and longest R-R interval in the first 15 s of squatting; SqTs: sympathetic index, or ratio between baseline 
cardiac R-R interval and shortest R-R interval in the first 10 to 20 s of standing after squatting; Pulsatile stress = PP × HR. 
 
4. Detection of diabetic CAN during a squat test 
4.1. Heart rate changes 
In healthy individuals during autonomic blockade, HR changes are mainly controlled by vagal tone (blocked by 
atropine) during squatting and sympathetic tone (blocked by propranolol) during standing [17,18]. Therefore, 
such HR responses may be useful for assessing the functional integrity of the parasympathetic and sympathetic 
nerves, respectively, in patients with DM. Marfella and colleagues [17] proposed calculating a so-called vagal 
index (SqTv, the ratio between the baseline cardiac R-R interval in the initial standing position and the longest 
R-R interval in the first 15 s of squatting) and a so-called sympathetic index (SqTs, the ratio between the 
baseline cardiac R-R interval and the shortest R-R interval in the first 10-20 s of standing after squatting). These 
indices, based on HR reduction during squatting and reflex tachycardia during standing, are considered markers 
of CAN: a higher SqTv value indicates parasympathetic neuropathy; while a lower SqTs is an indicator of 
sympathetic neuropathy (Table 1)[17]. 
Both SqTv and SqTs indices were calculated in a large cohort of healthy subjects and diabetic patients (one-third 
T1DM, two-thirds T2DM), all of whom submitted to standardized squat-testing [17]. Normal ranges of SqT 
ratios for healthy subjects aged 20-74 years showed a statistically significant negative correlation with age. The 
SqTv was outside the 99% confidence interval (CI) in 42% of the diabetic patients vs 1.3% of the control 
subjects; the corresponding figures for the SqTs were 40% and 0.8%, respectively. Age and duration of diabetes 
had a negative influence on both SqTv and SqTs ratios. In the same study, SqT ratios were compared with other 
reflex tests currently used for the diagnosis of CAN, including deep-breathing, lying-to-standing, the Valsalva 
manoeuvre and BP changes after standing (orthostatic hypotension) [2,11]. The conclusion was that SqT ratios 
can discriminate between healthy subjects and diabetic patients to an equal or greater extent than other tests, but 
are better than other tests on their own at identifying mild autonomic involvement [17]. 
The same Italian group reported that more diabetic patients treated with tolrestat, an aldose-reductase inhibitor, 
for 52 weeks had normalized SqTv or SqTs indices than those in the placebo group [23]. In another study, the 
same researchers reported that these squatting ratios significantly deteriorated after acute hyper-glycaemia in 
T2DM patients (P<0.01) [24]. Such changes were prevented by glutathione and reversed by L-arginine, 
suggesting their possible interference with endogenous nitric-oxide (NO) availability. Similar findings had been 
previously reported in healthy volunteers subjected to acute elevations of plasma glucose concentrations (15 
mmol/L, a level similar to that observed in poorly-controlled diabetic patients); in that study, hyper-glycaemia 
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produced relevant systemic haemodynamic changes (increases in BP and HR) and altered baroreflex activity 
(also assessed during a squat test). These haemodynamic changes were completely reversed by simultaneous 
infusion of glutathione, a free-radical scavenger that lowers oxidative stress, thereby suggesting a role for a 
glutathione-sensitive, presumably free-radical-mediated pathway [25]. 
 
Fig. 1. Changes in systolic blood pressure (SBP) and heart rate (beats/min) during a squat test (1-min standing, 1-min squatting, 1-min 
standing) in: (left column) a representative healthy subject (R-R E/I ratio = 1.38); (middle column) a patient with type 1 diabetes mellitus 
(T1DM) without cardiovascular autonomic neuropathy (CAN) (R-R E/I ratio= 1.41); and (right column) a patient with T1DM complicated 
by severe cardiovascular autonomic neuropathy (R-R E/I ratio= 1.08). The lowermost row shows the mode of calculation of baroreflex gain 




In a more recent study performed in Japanese T2DM patients, average changes in HR were calculated after 
completing the squatting (delta-HRSq) and standing (delta-HRSt) manoeuvre [18], and a positive correlation was 
noted between delta-HRSq and delta-HRSt (r = 0.86, P< 0.0001). Furthermore, both indices significantly 
correlated with baroreflex sensitivity, as measured using the phenylephrine reference method (see below; r = 
0.66, P<0.0001 and r = 0.61, P<0.0001, respectively). The authors concluded that these squatting-derived indices 
based on HR variations provide useful information for assessing CAN and for identifying diabetic patients at 
high risk of cardiovascular events. 
In a cross-sectional controlled study, 159 patients with T1DM of various durations were evaluated during a 3-
min squat test [16]. CAN was assessed by the R-R interval expiration/inspiration (E/I) ratio during deep 
breathing, and by the SqTv and SqTs squatting-derived indices according to Marfella et al. [17]. While the R-R 
E/I ratio (P<0.0001) progressively decreased with diabetes duration, the parasympathetic index SqTv 
significantly increased (P<0.0001), whereas the sympathetic index SqTs only tended towards decrease (P = 
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0.12). In contrast, no such changes in CAN indices were observed in an age-matched non-diabetic population. 
Classically, parasympathetic dysfunction precedes sympathetic dysfunction in diabetic CAN [1,2]. In agreement 
with this observation, the SqTv index was markedly and significantly affected by diabetes duration, whereas 
changes in SqTs failed to reach the level of statistical significance in this T1DM population. However, in a larger 
database with a better balance according to age [26], SqTv significantly increased and SqTs significantly 
decreased across various age groups (from 20 to 60 years) in a T1DM population, as was the case for the R-R E/I 
ratio (Fig. 2). In a controlled age-, gender- and BMI (body mass index)-matched non-diabetic population, SqTv 
significantly decreased according to age, but not SqTs. Furthermore, it was confirmed that both SqTv and SqTs 
indices were significantly altered in diabetes on comparing middle-aged patients with long-duration T1DM and 
their age-matched healthy, non-diabetic controls [27]. 
In a recent study [28], haemodynamic changes during a squat test were compared in 20 T1DM patients with low 
R-R E/I ratios during a deep-breathing test (used as a marker of CAN) and 40 matched healthy subjects. 
Compared with the controls, the diabetic patients had lower R-R E/I ratios (1.05 vs 1.29; P<0.00001), higher HR 
values throughout the posture test (90 vs 82 beats.mnr1; P = 0.0252) and reduced reflex tachycardia following 
the transition from squatting to standing (+18 vs +32 beats.mnr1; P = 0.0004), thereby significantly reducing 
SqTs (1.10 vs 1.22; P = 0.0001). 
 
Fig. 2. Comparison of various indices (means ± SD) of cardiovascular autonomic neuropathy (CAN) according to age (G1: 20-30 years; 
G2: 31-40 years; G3: 41-50 years; G4: 51-60 years; n = 40 in each group) in patients with type 1 diabetes (black histograms) vs age-, 
gender- and BMI (body mass index)-matched healthy subjects (white histograms): R-R expiration/inspiration (E/I) ratio; vagal index (SqTv); 
sympathetic index (SqTs); and baroreflex gain (BRG). Statistical analysis used analysis of variance (Anova) for trends with age in each 
population (stars in boxes), and Student's unpaired t test for differences between diabetic patients and non-diabetic subjects in each age 
group (stars above each pair of histograms). Data are from the cohort reported in Philips et al. [26]. 
 
 
4.2. Blood pressure changes 
The standing-squatting shift normally results in a transient first-phase BP burst followed by a secondary, more 
sustained, BP rise that, nevertheless, is still of somewhat small amplitude in healthy subjects (Fig. 1) [12]. It was 
reported in a large cohort of 159 T1DM patients that squatting was associated with a greater increase in BP and 
PP according to diabetes duration (especially after 20 years of disease duration) and age than in non-diabetic 
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controls, a finding that was attributed to accelerated arterial stiffness resulting from chronic hyperglycaemia [16, 
29]. In patients with T1DM and orthostatic hypotension (due to advanced CAN), a larger, sustained increase in 
BP was observed in the squatting position (Fig. 1), an observation in agreement with the use of squatting to 
counteract dizziness due to orthostatic hypotension in subjects with autonomic dysfunction [15]. However, 
whether the increase in BP and PP during squatting can exaggerate cardiovascular risk in certain conditions 
and/or some patients remains unknown. 
The transition from squatting to standing results in an abrupt transient fall in BP that, in healthy subjects, is 
followed by a rapid return to baseline values according to a biphasic response (Fig. 1). In one detailed 
description, mean BP reached minimum after 7 s and, thereafter, increased to a new level, close to baseline level, 
within around 15 s [8]. 
A pilot study compared BP changes during three posture tests (lying-to-standing, sitting-to-standing and a squat 
test) in 10 healthy subjects, 10 T2DM patients without CAN and 10 T2DM patients with CAN assessed by the 
presence of a pathological R-R E/I ratio during a deep-breathing test [13]. A significantly greater BP drop was 
seen in T2DM patients with CAN compared with T2DM patients without CAN and the non-diabetic subjects 
(P< 0.001). Significant correlations were also observed between BP fall after squatting and either the R-R E/I 
ratio on deep breathing (r = -0.77, P<0.001) or the duration of diabetes (r = 0.76, P<0.001). Thus, the intrinsic 
orthostatic load of the squat test, which is greater than those in conventional postural manoeuvres [10,13,14], 
makes squatting a useful test for detecting early autonomic dysregulation leading to orthostatic hypotension 
[13,15]. 
In a similar, more recent study [28], haemodynamic changes during an active orthostatic test were compared in 
20 T1DM patients with low R-R E/I ratios during a deep-breathing test (used as a marker of CAN) and 40 
matched healthy subjects. Compared with the controls, the diabetic patients did not exhibit any significantly 
greater initial BP drop but, instead, showed a delayed BP return to baseline after standing (33 vs 21s; P = 
0.0167); this abnormal response may be explained by dampened reflex tachycardia and presumably by reduced 
sympathetic-driven vasoconstriction. 
4.3. Baroreflex sensitivity 
Considered one of the most sensitive and specific approaches currently available to evaluate CAN in clinical 
research [11], the sensitivity of the arterial baroreflex (baroreflex gain, BRG) is routinely calculated from the 
relationship between HR increase and/or decrease responses (translated into respective R-R interval changes) 
and decreases and/or increases in arterial systolic BP [30, 31]. The classical assessment of BRG uses a 
pharmacological approach, involving the infusion of angiotensin or phenylephrine to generate a vasopressor 
stimulus, associated with reflex bradycardia, and nitroprusside or amyl nitrite to induce vasodilatation and a fall 
in BP, associated with reflex tachycardia [32]. These pharmacological tools were designed to drastically perturb 
the system, thereby inducing rapid and large HR responses to facilitate the assessment of reflex gain. Indeed, 
baroreceptor responses are most apparent with rapidly changing pressures, rather than stationary or minimally 
changing BP levels during continuous monitoring under resting conditions [33]. It has also been reported that 
measurements of baroreflex sensitivity using non-invasive methods (Finapres) are highly correlated with 
measurements using intra-arterial invasive methods and can provide the equivalent prognostic information [34]. 
As previously reported by our group [16] and others [35, 36], and as recently described in detail [12, 16], the 
squat test can be used as an alternative dynamic procedure to assess BRG. During the transition from squatting to 
standing, there is an abrupt drop in BP associated with reflex tachycardia, and the initial changes are followed by 
a rapid return to the baseline values of both parameters (secondary BP increase and HR decrease; Fig. 1). 
Propranolol can markedly attenuate reflex tachycardia on standing from squatting [17, 18]. The large biphasic 
mirrored changes in HR and systolic BP during a squat-stand test allow the calculation of BRG; indeed, such 
haemodynamic changes are almost identical to those seen with a vasodilator drug (hypotension with reflex 
tachycardia) and a vasoconstrictor agent (hypertension associated with bradycardia), although the haemodynamic 
changes occur more quickly in the squat test [18,30]. As previously described [12], BRG can be calculated by 
plotting the pulse intervals (R-R) against systolic BP following the transition phase from squatting to standing. 
The slope represents baroreflex sensitivity [36], and corresponds to changes in R-R pulse intervals per mm 
change in systolic BP (Fig. 1). Acceptable reproducibility of BRG measurement was also demonstrated in 70 
(diabetic and non-diabetic) subjects who performed two squat-stand tests [12]. The BRG results in healthy 
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Table 2: Comparison of baroreflex gain (BRG) calculated during a squat-stand test in patients with type 1 
diabetes (T1DM), according to various criteria, and patients with type 2 diabetes (T2DM). 
Subjects (group 1 vs group 
2) and criteria 
Reference BRG group 1 BRG group 2 P 
T1DM by diabetes 
duration:  
< 10 vs 21-30years 
Philips et al., 2009 [16] 4.06 ± 2.42 (n = 39) 2.23 ± 1.95 (n = 57) 0.00024 
T1DM by age: 
20-30 vs 51-60 years 
Philips et al., 2010 [26] 4.10 ± 2.93 (n = 40) 1.93 ± 1.74 (n = 40) 0.0002 
T1DM by R-RE/I ratio: 
high (mean 1.27) vs low 
(mean 1.05) 
Philips et al., 2011 [28] 2.43 ± 1.57 (n = 20) 1.39 ± 1.39 (n = 20) 0.0374 
T1DM by µA:  
<30 vs >30mg/L 
Scheen et al., 2011 [37] 3.07 ± 2.45 (n = 136) 1.55 ± 1.67 (n = 26) 0.0005 
T1DM by pulsatile stress:a 
<4500 vs > 4500 
mmHg.min-1 
Philips et al., 2010 [26] 3.33 ± 2.73 (n = 70) 2.52 ± 1.91 (n = 90) 0.038 
T1DM by HbA1c:b 
<8%(mean7.4) vs >8% 
(mean 9.4) 
Philips et al., 2004 [38] 3.05 ± 1.10 (n = 21) 2.13 ± 1.59 (n = 27) 0.037 
Middle-aged (50 years): 
lean controls vs T1DM 
patients 
Philips et al., 2010 [27] 4.11 ± 2.26 (n = 40) 2.20 ± 1.73 (n = 40) 0.0002 
Middle-aged (50 years): 
obese controls vs T2DM 
patients 
Philips et al., 2010 [27] 2.97 ± 2.18 (n = 40) 2.05 ± 1.31 (n = 40) 0.0351 
Results are expressed as means ± SD; « = number of subjects; µA: microalbuminuria. 
a PP × HR, calculated during the whole 3-min squatting test. 
b In a longitudinal study after a mean follow-up of 43 ± 17 months, BRG significantly decreased from 3.89 to 2.13 ms/mmHg (P = 0.02) in 




BRG measurements during a squat test have been used extensively by our group to assess CAN in diabetic 
individuals, mostly patients with T1DM. As summarized in Table 2, it was previously demonstrated that 
baroreflex gain is significantly reduced in T1DM patients with (a) longer disease duration [16], (b) greater age 
[26], (c) low R-R E/I ratios [28], (d) microalbuminuria (µA) [37], (e) increased pulsatile stress [26], (f) poor 
metabolic control [38] and (g) compared with age-matched middle-aged non-diabetic individuals (which was 
also the case for T2DM patients compared with weight- and age-matched healthy subjects) [27]. 
In addition, it was previously reported that BRG progressively decreased according to duration of disease in a 
population of patients with T1DM, whereas such areduction was not significant in a control non-diabetic 
population matched for age [16]. In a larger database [26], the progressive reduction in BRG according to age 
was more pronounced in T1DM patients compared with an age-, gender- and BMI-matched non-diabetic 
population (Fig. 2). Our results might suggest that BRG reduction occurs at an earlier stage than the R-R E/I 
ratio in the natural history of CAN in T1DM patients. These observations, obtained during a squat test, are in 
agreement with previous data reporting barore-ceptor cardiac reflex sensitivity measured during phase 4 of the 
Valsalva manoeuvre [39]. In that study, reductions in baroreflex sensitivity were detected in T1DM patients 
compared with controls (although standard tests of autonomic function revealed no significant differences). 
Furthermore, there were significant relationships between baroreflex impairment and the duration of diabetes 
(P< 0.001) and poor diabetes control (P< 0.05). 
On comparing the relationship of two markers of CAN — the R-R E/I ratio measured during a deep-breathing 
test and BRG assessed during a squat test—with µA and pulsatile stress (the product of PP and HR) in 167 
patients with T1DM [37], the patients with low BRG had an increased pulsatile stress index, especially in 
squatting position (P<0.0001). Similarly, µA was significantly higher in T1DM patients with low BRG (P = 
0.0001). Also, there was an inverse correlation between BRG and log µA (r = -0.28, P = 0.0006), but not 
between R-R E/I ratio and log µA (r = 0.09, P = 0.12). Thus, the calculation of BRG during a squat-stand test in 
patients with T1DM allows for better detection of those patients with increased pulsatile stress, and even more so 
in patients with µA, than the classical CAN index R-R E/I ratio. Thus, a decreased BRG measured during a squat 
test may be used to detect T1DM patients at high risk of cardiorenal complications compared with other current 
techniques [40]. 
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In addition, to investigate the influence of blood glucose control on the progression of indices of CAN in patients 
with T1DM, 48 patients were subjected twice to a squat test over a time interval of 43 ± 17 months (range: 16-91 
months) [38]. Overall blood glucose control was estimated by the mean value of several glycated haemoglobin 
(HbA1c) measurements between the two tests, and patients were separated into two subgroups: HbA1c levels < 
8% (in 21 patients; 7.42 ± 0.60%) vs> 8% (in 27 patients; 9.44 ± 1.04%). BRG tended to be negatively related 
(P<0.10) to the duration of diabetes at the initial evaluation (19 ±10 years, range: 3-38 years). Overall, this index 
of CAN decreased from 4.00 ±3.41 to 2.53 ± 1.46 ms/mmHg 
(P = 0.008) during the 3.5-year period separating the two ortho-static tests. The BRG reduction was significant 
in patients with poor glucose control (from 3.89 to 2.13ms/mmHg; P = 0.02), but not in patients with acceptable 
control (from 4.16 to 3.05ms/mmHg; not significant, NS). While no significant differences were observed 
between the two groups at the initial evaluation, BRG was significantly lower at the second evaluation in the 
poorly-controlled vs better-controlled group (P<0.05; Table 2). Significant negative correlations were also found 
between changes in BRG from test 1 to test 2 and mean HbAlc levels during the period between the two tests (r = 
-0.304, P<0.01), and between BRG at the second evaluation and the corresponding averaged HbA1c levels           
(r =-0.409, P < 0.001), thereby confirming previous observations from a cross-sectional study [39]. Thus, in 
patients with long-standing (almost 20 years) T1DM, a period of 3 to 4 years with poor glucose control is 
sufficient to significantly decrease BRG [38]. 
These longitudinal observations need to be confirmed in a larger cohort of patients with longer follow-up. 
Interestingly, in the Diabetes Control and Complications Trial (DCCT), T1DM patients (duration of disease < 15 
years) were randomly assigned to either conventional (mean HbAlc around 9%) or intensive (mean HbAlc around 
7%) therapy and followed for up to 9 years. Baseline and biannual measurements of autonomic function (R-R 
E/I variation, Valsalva ratio and postural testing) were performed throughout the trial. In general, autonomic 
abnormalities increased; however, R-R variation was less frequently abnormal in the intensively treated and 
better-controlled T1DM patients (an almost 2% difference in HbAlc level, as in our study) [41]. The 
Epidemiology of Diabetes Interventions and Complications (EDIC) study, a prospective observational follow-up 
of the DCCT cohort, reported persistent benefits with prior intensive therapy of CAN 13 to 14 years after the 
DCCT closeout. Prior DCCT intensive therapy (and, thus, better glucose control) reduced the risks of incident 
CAN by almost 30% [42]. Similarly, in the Steno-2 trial, a target-driven, long-term, intensified intervention 
aimed at multiple risk factors in patients with T2DM (and also aiming to improve glucose control) reduced the 
risk of CAN by almost 60% after a mean follow-up of around 8 years [43]. These consistent results highlight the 




A recent consensus document critically reviewed the limitations and strengths of the available diagnostic 
approaches for CAN, and emphasized the need to develop new tests of autonomic function, although baroreflex 
sensitivity measurement is still considered to be among the most sensitive and specific approaches [11]. Our 
group used an original posture test, the squat test, to detect early signs of CAN in patients with DM. The 
substantial biphasic changes in systolic BP and HR arising during the initial squat-stand transition phase mimic 
those observed during pharmacological tests using vasodila-tor/vasopressor agents. By plotting the R-R intervals 
according to systolic BP changes following the squat-stand transitions, the calculated BRG may be used to assess 
cardiovagal baroreflex sensitivity and autonomic function. It was also demonstrated that a BRG reduction 
calculated during a squat test is more informative for detecting early CAN in patients with T1DM than a 
decreased R-R E/I ratio measured during a deep-breathing test, a classical CAN index widely used in clinical 
research, or other squatting-related indices derived only from HR changes. Although some individuals (such as 
the elderly and very obese) may find it difficult or even impossible to perform the squatting manoeuvre, in our 
experience, most patients with T1DM can be appropriately evaluated by this posture test. 
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